Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
Fish and Richardson
Accenture
Teva
Cantor Fitzgerald
McKinsey
Argus Health
Boehringer Ingelheim
Deloitte
Chubb

Generated: January 22, 2018

DrugPatentWatch Database Preview

NORLESTRIN 21 1/50 Drug Profile

« Back to Dashboard

When do Norlestrin 21 1/50 patents expire, and when can generic versions of Norlestrin 21 1/50 launch?

Norlestrin 21 1/50 is a drug marketed by Parke Davis and is included in one NDA.

The generic ingredient in NORLESTRIN 21 1/50 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.

US Patents and Regulatory Information for NORLESTRIN 21 1/50

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Parke Davis NORLESTRIN 21 1/50 ethinyl estradiol; norethindrone acetate TABLET;ORAL-21 016749-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Federal Trade Commission
Johnson and Johnson
Novartis
Daiichi Sankyo
Covington
Express Scripts
Fuji
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot